Syndax Pharmaceuticals director Dennis Podlesak sells $113,716 in stock

A director of Syndax Pharmaceuticals, Dennis Podlesak, sold $113,716 in company stock. This transaction was reported on October 30, 2026.

Details about the sale have been reported by Investing.com and Investing.com España. The sales amount to $113,716, according to these sources. There is no additional information available about the reasons for the sale.

Similar stock sales have been reported for other company directors. A director of Alphabet, Frances Arnold, sold $23,288 in class C stock, while a director of The Cheesecake Factory sold $48,326 in common stock. These transactions were also reported on October 30, 2026.

What motivated these sales and what the directors plan to do with the proceeds has not been reported yet. Further details about the transactions may be available in future regulatory filings.